Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: Correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factor
- 1 January 1993
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 168 (1) , 71-78
- https://doi.org/10.1016/s0002-9378(12)90888-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Homologous activators of ras in fission and budding yeastNature, 1990
- Amplification of c-ras-ki oncogene in human ovarian tumoursInternational Journal of Cancer, 1989
- A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomasCancer, 1988
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomasNucleic Acids Research, 1988
- Expression of H-ras correlates with metastatic potential: evidence for direct regulation of the metastatic phenotype in 10T1/2 and NIH 3T3 cells.Molecular and Cellular Biology, 1987
- Primary structure of the α-subunit of transducin and its relationship to ras proteinsNature, 1985
- The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activityNature, 1984
- CELLULAR ONCOGENES AND RETROVIRUSESAnnual Review of Biochemistry, 1983
- A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogeneNature, 1982